Stay updated on Pembrolizumab Amurubicin Combo in Refractory SCLC Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab Amurubicin Combo in Refractory SCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab Amurubicin Combo in Refractory SCLC Clinical Trial page

  1. Check
    7 days ago
    No Change Detected
  2. Check
    14 days ago
    No Change Detected
  3. Check
    21 days ago
    No Change Detected
  4. Check
    29 days ago
    Change Detected
    Summary
    Footer now shows Revision: v3.3.3; references to HHS Vulnerability Disclosure and Revision: v3.3.2 have been removed.
    Difference
    0.1%
    Check dated 2025-12-19T09:58:51.000Z thumbnail image
  5. Check
    50 days ago
    Change Detected
    Summary
    The page now displays Revision: v3.3.2, replacing Revision: v3.3.1.
    Difference
    0.1%
    Check dated 2025-11-27T23:17:57.000Z thumbnail image
  6. Check
    57 days ago
    Change Detected
    Summary
    The Publications note now states that publications are automatically filled in from PubMed, replacing the previous wording. The revision tag was updated to Revision: v3.3.1 (replacing v3.2.0).
    Difference
    0.1%
    Check dated 2025-11-20T22:12:34.000Z thumbnail image
  7. Check
    64 days ago
    Change Detected
    Summary
    Removed the government funding status banner from the page; To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2025-11-13T15:45:01.000Z thumbnail image
  8. Check
    79 days ago
    Change Detected
    Summary
    No additions or deletions were detected for the Study Details page (NCT03253068). The content appears unchanged.
    Difference
    0.5%
    Check dated 2025-10-30T09:00:40.000Z thumbnail image
  9. Check
    108 days ago
    Change Detected
    Summary
    Page updated from Revision: v3.0.2 to Revision: v3.2.0.
    Difference
    0.1%
    Check dated 2025-10-01T02:37:17.000Z thumbnail image

Stay in the know with updates to Pembrolizumab Amurubicin Combo in Refractory SCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab Amurubicin Combo in Refractory SCLC Clinical Trial page.